Burayzat Salma, Elsahoryi Nour, Freitekh Ali, Alzoubi Osama, Al-Najjar Rahaf, Tayyem Reema
Pediatric Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, Pediatrics Department, The Hashemite University, Zarqa 13133, Jordan.
Faculty of Pharmacy and Medical Sciences, Nutrition Department, University of Petra, Amman 961343, Jordan.
Children (Basel). 2022 Aug 18;9(8):1247. doi: 10.3390/children9081247.
Background: Children diagnosed with type 1 diabetes mellitus (T1DM) are more prone to having celiac disease (CD) than the normal population. Moreover, patients with this dual diagnosis who are also on a diabetic and gluten-free diet (GFD) risk faltering growth and uncontrolled blood glucose levels. This review aims to assess the efficacy and effectiveness of managing patients with T1DM screened for CD with GFD to prevent complications associated with these chronic pathologies in childhood and adulthood. Materials and Methods: We abided by the PRISMA guidelines in this meta-analysis and used multiple databases and search engines. We included case−control studies. The primary outcomes were changes in the standard deviation score, body mass index (SDS BMI), and glycosylated hemoglobin (HA1C) after being on a GFD for at least twelve months. Results: The pooled data from the six studies included showed that there was neither a statistically significant difference in the mean SDS BMI (−0.28 (95% CI −0.75, 0.42)) (p = 0.24) nor in the mean of HA1C (mean −0.07 (95% CI −0.44, 0.30)) (p = 0.36) for the same group. HDL cholesterol improved significantly in patients on a strict GFD (p < 0.01). Conclusions: In children with T1DM and asymptomatic CD, being on a GFD had no significant effect on BMI or HA1C. However, it can have a protective effect on the other complications found in both chronic pathologies.
被诊断为1型糖尿病(T1DM)的儿童比正常人群更容易患乳糜泻(CD)。此外,患有这种双重诊断且同时采用糖尿病和无麸质饮食(GFD)的患者有生长发育迟缓以及血糖水平控制不佳的风险。本综述旨在评估对筛查出患有CD的T1DM患者采用GFD进行管理,以预防儿童期和成年期与这些慢性疾病相关并发症的疗效和有效性。
在这项荟萃分析中,我们遵循PRISMA指南,并使用了多个数据库和搜索引擎。我们纳入了病例对照研究。主要结局指标是采用GFD至少十二个月后的标准差评分、体重指数(SDS BMI)和糖化血红蛋白(HA1C)的变化。
纳入的六项研究的汇总数据显示,同一组患者的平均SDS BMI(-0.28(95%CI -0.75,0.42))(p = 0.24)和平均HA1C(平均-0.07(95%CI -0.44,0.30))(p = 0.36)均无统计学显著差异。严格遵循GFD饮食的患者高密度脂蛋白胆固醇显著改善(p < 0.01)。
对于患有T1DM和无症状CD的儿童,采用GFD对BMI或HA1C没有显著影响。然而,它对这两种慢性疾病中发现的其他并发症可能具有保护作用。